Bharat Parenterals Limited (BOM:541096)
India · Delayed Price · Currency is INR 1,530.20
+93.80 (6.53%)
At close: Jul 27, 2026
Bharat Parenterals Market Cap
Bharat Parenterals has a market cap or net worth of 10.55 billion as of July 28, 2026. Its market cap has decreased by -1.28% in one year.
Market Cap
10.55B
Enterprise Value
11.73B
Revenue
3.45B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,530.20
ChartMarket Cap Chart
Since March 21, 2018, Bharat Parenterals's market cap has increased from 914.45M to 10.55B, an increase of 1,053.26%. That is a compound annual growth rate of 33.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 10.55B | 26.52% |
| Dec 31, 2025 | 8.34B | -12.96% |
| Dec 31, 2024 | 9.58B | 103.12% |
| Dec 29, 2023 | 4.71B | 148.91% |
| Dec 30, 2022 | 1.89B | -13.76% |
| Dec 31, 2021 | 2.20B | 8.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fredun Pharmaceuticals | 14.80B |
| Amrutanjan Health Care | 14.76B |
| Shukra Pharmaceuticals | 13.94B |
| Fermenta Biotech | 12.40B |
| Syncom Formulations (India) | 12.31B |
| Lincoln Pharmaceuticals | 11.66B |
| Wanbury | 11.60B |
| Sudarshan Pharma Industries | 10.06B |